Actively Recruiting
An Efficacy Study of a Dietary Supplement Drink Mix for Urinary Health Improvement
Led by Bonafide Health · Updated on 2026-03-06
210
Participants Needed
1
Research Sites
75 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a 6-month, three-arm randomized controlled trial evaluating the efficacy and safety of a dietary supplement drink mix on urinary health outcomes in adult females. Participants will be randomly assigned to one of three study arms and followed for six months to assess changes in urinary health measures.
CONDITIONS
Official Title
An Efficacy Study of a Dietary Supplement Drink Mix for Urinary Health Improvement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy biological females aged 18 to 75 years
- History of recurrent uncomplicated UTI (2 or more UTIs in last 6 months and/or 3 or more UTIs in last 12 months)
- Within 7 days of an acute UTI enrollment trigger event
- In good general health and able to consume the study product
- Body Mass Index (BMI) between 18.5 and 39.9 kg/m^2
- Have reliable, stable access to Wi-Fi and a smartphone or device
- Willing and able to consent, understand questionnaires, and follow study procedures
You will not qualify if you...
- Lactating, pregnant, or planning pregnancy during the study
- Currently participating in another clinical trial
- Using treatments for menopausal symptoms or other concomitant treatments
- Known allergy or intolerance to study products or excipients
- History of high potassium (hyperkalemia) or chronic kidney disease
- Use of antibiotics unrelated to UTI during the trial
- Current use of D-mannose (unless completing a 2-week washout)
- Previous use of the FLUSH product
- Current use of antibiotic-based prophylaxis
- History of diabetes mellitus (Type 1 or 2)
- Use of vaginal or local estrogen therapy (unless stable dose >90 days)
- Active or suspected vaginitis
- Started new non-antibiotic prophylaxis within last 90 days
- Use of probiotics (unless stable oral dose >90 days)
- Use of urinary catheterization
- Diagnosis of overactive bladder or interstitial cystitis/bladder pain syndrome
- Urologic procedure within 6 months before enrollment
- History of structural urinary tract disease or Lichen sclerosis
- Use of potassium-sparing medications such as spironolactone, ACE inhibitors, ARBs, or systemic calcineurin inhibitors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bonafide Health
Harrison, New York, United States, 10528
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here